Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PVLAthis companyPalvella Therapeutics, Inc.	$174.55	-28.21×	42.09×	0×	-31.21×	-96.8%	0.0%	0.0%	0.0%	-149.1%	-79.7%	-2.1%	0.02×	1.6×	-6.63×	5.2×	0.0%	3	33.98	2	C
DERMJourney Medical Corporation	$4.55	-16.4×	5.93×	3.05×	-57.16×	-300.3%	59.3%	-13.2%	-18.5%	-35.9%	-14.3%	-6.6%	0.8×	-0.39×	-2.21×	1.79×	0.0%	4	0.73	1	D+
QNRXQuoin Pharmaceuticals, Ltd.	$3.71	-1.36×	1.65×	0×	241.74×	63270.6%	0.0%	0.0%	0.0%	-120.5%	-109.7%	-62.6%	0×	243.12×	0×	3.61×	0.0%	1	-13.64	2	C+
VRCAVerrica Pharmaceuticals Inc.	$3.48	-4.95×	3.58×	2.49×	-6.41×	-495.6%	90.3%	-33.6%	-50.3%	-72.3%	-38.0%	-19.9%	0.07×	3.05×	-1.54×	2.59×	0.0%	4	-13.81	1	D+
Peer median	—	-4.95×	3.58×	2.49×	-6.41×	-300.3%	59.3%	-13.2%	-18.5%	-72.3%	-38.0%	-19.9%	0.07×	3.05×	-1.54×	2.59×	0.0%	4	-13.64	1	—